1. Home
  2. TFPM vs BIO Comparison

TFPM vs BIO Comparison

Compare TFPM & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

TFPM

Triple Flag Precious Metals Corp.

HOLD

Current Price

$30.31

Market Cap

6.8B

Sector

Industrials

ML Signal

HOLD

Logo Bio-Rad Laboratories Inc.

BIO

Bio-Rad Laboratories Inc.

HOLD

Current Price

$262.97

Market Cap

7.1B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
TFPM
BIO
Founded
2016
1952
Country
Canada
United States
Employees
N/A
7450
Industry
Precious Metals
Biotechnology: Laboratory Analytical Instruments
Sector
Industrials
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
6.8B
7.1B
IPO Year
2022
N/A

Fundamental Metrics

Financial Performance
Metric
TFPM
BIO
Price
$30.31
$262.97
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
4
Target Price
$35.33
$358.50
AVG Volume (30 Days)
535.0K
235.7K
Earning Date
02-18-2026
04-30-2026
Dividend Yield
0.72%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$26.66
$2.74
Revenue Next Year
N/A
$3.05
P/E Ratio
$35.57
$9.72
Revenue Growth
N/A
N/A
52 Week Low
$17.72
$211.43
52 Week High
$41.70
$343.12

Technical Indicators

Market Signals
Indicator
TFPM
BIO
Relative Strength Index (RSI) 27.76 40.24
Support Level $27.14 $239.33
Resistance Level $33.48 $289.61
Average True Range (ATR) 1.46 7.46
MACD -1.01 0.44
Stochastic Oscillator 4.24 19.99

Price Performance

Historical Comparison
TFPM
BIO

About TFPM Triple Flag Precious Metals Corp.

Triple Flag Precious Metals Corp is a streaming and royalty company focused on precious metals. Its revenues are largely generated from a diversified portfolio of properties in Australia, Canada, Colombia, Cote d'Ivoire, Mexico, Mongolia, Peru, South Africa, and the United States. Its diversified portfolio of streams and royalties comprises long-life mining assets, including the Northparkes copper-gold mine in Australia, the Cerro Lindo polymetallic mine in Peru, the Fosterville gold mine in Australia, the Buritica gold mine in Colombia, and the Impala Bafokeng Operations in South Africa among others. A majority of its revenue is derived through its interests in various gold streams. Geographically, the company derives maximum revenue from Australia, followed by Peru and other regions.

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

Share on Social Networks: